BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20037431)

  • 1. A rare case of liver regenerative and non-neoplastic lesion resembling a well-differentiated hepatocellular carcinoma.
    Hirose K; Toshima T; Tobo T; Kai S; Hirakawa M; Higuchi S; Ofuchi T; Hosoda K; Yonemura Y; Hisamatsu Y; Masuda T; Aishima S; Mimori K
    Surg Case Rep; 2024 Feb; 10(1):30. PubMed ID: 38300348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosing hemangiomas mimicking hepatocellular carcinoma: A case report.
    Zhan X; Gao Y; Xu J; Wu D; Wang P; Zhou H
    Int J Immunopathol Pharmacol; 2023; 37():3946320231190898. PubMed ID: 37614092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of difficult-to-diagnose hepatic reactive lymphoid hyperplasia finally diagnosed by using PCR analysis of IgH-gene rearrangements: a case report.
    Mita J; Maeda T; Tsujita E; Yugawa K; Takaki S; Tsuji K; Hashimoto N; Fujikawa R; Ono Y; Sakai A; Tanaka S; Matono R; Ohmine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
    Int Cancer Conf J; 2024 Jan; 13(1):33-39. PubMed ID: 38187175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma.
    Okada M; Numata K; Nihonmatsu H; Tomita K; Takeda A; Tago K; Hyodo T; Eriguchi T; Nakano M
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hepatic undiferentiated pleomorphic sarcoma co-existed with hepatocellular carcinoma.
    Qu J; Cao Q; Zhang M; Liu Y; Li J
    Rev Esp Enferm Dig; 2023 Oct; ():. PubMed ID: 37882154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():87-93. PubMed ID: 20616589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of glycogen storage disease type I with hepatocellular carcinoma].
    Okuda Y; Ota H; Mikami K; Nagase H; Mukai R; Okada K; Ide Y; Yanagisawa T; Maruyama K; Murata K; Yokouchi H; Nagase A; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2362-4. PubMed ID: 20037423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of hepatocellular carcinoma which could be diagnosed with Gd-EOB-DTPA enhanced MRI].
    Ota H; Mikami K; Nagase A; Nagase H; Mukai R; Okada K; Ide Y; Maruyama K; Murata K; Yokouchi H; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2386-8. PubMed ID: 20037431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
    Kudo M; Matsui O; Sakamoto M; Kitao A; Kim T; Ariizumi S; Ichikawa T; Kobayashi S; Imai Y; Izumi N; Fujinaga Y; Arii S
    Oncology; 2013; 84 Suppl 1():21-7. PubMed ID: 23428854
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.